Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies
- PMID: 10453810
- DOI: 10.1093/oxfordjournals.aje.a010013
Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies
Abstract
In prospective studies, disease rates during follow-up are typically analyzed with respect to the values of factors measured during an initial baseline survey. However, because of "regression dilution," this generally tends to underestimate the real associations of disease rates with the "usual" levels of such risk factors during some particular exposure period. The "regression dilution ratio" describes the ratio of the steepness of the uncorrected association to that of the real association. To assess the relevance of the usual value of a risk factor during particular exposure periods (e.g., first, second, and third decades) to disease risks, regression dilution ratios can be derived by relating baseline measurements of the risk factor to replicate measurements from a reasonably representative sample of study participants after an interval equivalent to about the midpoint of each exposure period (e.g., at 5, 15, and 25 years, respectively). This report illustrates the impact of this time interval on the magnitude of the regression dilution ratios for blood pressure and blood cholesterol. The analyses were based on biennial remeasurements over 30 years for participants in the Framingham Study (Framingham, Massachusetts) and a 26-year resurvey for a sample of men in the Whitehall Study (London, England). They show that uncorrected associations of disease risk with baseline measurements underestimate the strength of the real associations with usual levels of these risk factors during the first decade of exposure by about one-third, the second decade by about one-half, and the third decade by about two-thirds. Hence, to correct appropriately for regression dilution, replicate measurements of such risk factors may be required at varying intervals after baseline for at least a sample of participants.
Similar articles
-
Regression dilution bias in blood total and high-density lipoprotein cholesterol and blood pressure in the Glostrup and Framingham prospective studies.J Cardiovasc Risk. 2003 Apr;10(2):143-8. doi: 10.1097/01.hjr.0000060834.46105.3c. J Cardiovasc Risk. 2003. PMID: 12668912
-
Underestimation of the importance of blood pressure and cholesterol for coronary heart disease mortality in old age.Eur Heart J. 2002 Feb;23(4):286-93. doi: 10.1053/euhj.2001.2781. Eur Heart J. 2002. PMID: 11812064
-
Extent of regression dilution for established and novel coronary risk factors: results from the British Regional Heart Study.Eur J Cardiovasc Prev Rehabil. 2004 Apr;11(2):125-34. doi: 10.1097/01.hjr.0000114967.39211.e5. Eur J Cardiovasc Prev Rehabil. 2004. PMID: 15187816
-
Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths.Lancet. 2007 Dec 1;370(9602):1829-39. doi: 10.1016/S0140-6736(07)61778-4. Lancet. 2007. PMID: 18061058 Review.
-
Blood pressure, cholesterol, and common causes of death: a review. Prospective Studies Collaboration.Am J Hypertens. 1999 Oct;12(10 Pt 2):96S-98S. doi: 10.1016/s0895-7061(99)00162-4. Am J Hypertens. 1999. PMID: 10555608 Review.
Cited by
-
Novel circulating fatty acid patterns and risk of cardiovascular disease: the Cardiovascular Health Study.Am J Clin Nutr. 2012 Dec;96(6):1252-61. doi: 10.3945/ajcn.112.039990. Epub 2012 Oct 24. Am J Clin Nutr. 2012. PMID: 23097270 Free PMC article.
-
A pilot study identifying statin nonadherence with visit-to-visit variability of low-density lipoprotein cholesterol.Am J Cardiol. 2013 May 15;111(10):1437-42. doi: 10.1016/j.amjcard.2013.01.297. Epub 2013 Feb 20. Am J Cardiol. 2013. PMID: 23433758 Free PMC article.
-
L-shaped association of serum 25-hydroxyvitamin D concentrations with cardiovascular and all-cause mortality in individuals with osteoarthritis: results from the NHANES database prospective cohort study.BMC Med. 2022 Sep 21;20(1):308. doi: 10.1186/s12916-022-02510-1. BMC Med. 2022. PMID: 36127705 Free PMC article.
-
Aldosterone antagonists and outcomes in real-world older patients with heart failure and preserved ejection fraction.JACC Heart Fail. 2013 Feb;1(1):40-7. doi: 10.1016/j.jchf.2012.08.001. JACC Heart Fail. 2013. PMID: 23814702 Free PMC article.
-
Digoxin use and lower 30-day all-cause readmission for Medicare beneficiaries hospitalized for heart failure.Am J Med. 2014 Jan;127(1):61-70. doi: 10.1016/j.amjmed.2013.08.027. Epub 2013 Nov 18. Am J Med. 2014. PMID: 24257326 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical